- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
- Media
- Partners
- Contact Us
Dr. Reddy's in the news
-
Aster DM Healthcare partners with Dr Reddy's to administer Sputnik V vaccine in select locations
Click Here for the Complete Story [PDF Format] -
Sputnik V vaccine makes debut in Mumbai as part of pilot project
Click Here for the Complete Story [PDF Format] -
Sputnik V more efficien against Delta strain of COVID-19 compared to any other jab: Sputnik V
Click Here for the Complete Story [PDF Format] -
Access to DRDO drug 2-DG will improve in weeks: Dr.Reddy's
Click Here for the Complete Story [PDF Format] -
Sputnik V debuts in Kolkata, 150 get jabs
Click Here for the Complete Story [PDF Format] -
DRDO issues directions on usage of anti-COVID drug 2-DG
Click Here for the Complete Story [PDF Format] -
Single-dose Sputnik Light could be first single-dose vaccine launched in India
Click Here for the Complete Story [PDF Format] -
Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy's & RDIF
Click Here for the Complete Story [PDF Format] -
Dr Reddy's administers first dose of Sputnik V vaccine, imported doses at RS 995/jab
Click Here for the Complete Story [PDF Format] -
Dr Reddy's is not as big in India as it should be. We want to grow more.
Click Here for the Complete Story [PDF Format] -
Why a New Expat CEO may be Good News for Dr Reddy's
Click Here for the Complete Story [PDF Format] -
Indian Pharma Industry: From cultural practices to being quality-intensive
Click Here for the Complete Story [PDF Format]
